GRAIL Will Be Listed And Commence Regular-Way Trading On The Nasdaq Under The Symbol "GRAL" As Of June 25, 2024.
GRAIL Will Be Listed And Commence Regular-Way Trading On The Nasdaq Under The Symbol "GRAL" As Of June 25, 2024.
2024年6月25日，格雷尔将在纳斯达克上市，并在标的为“GRAL”的常规交易下开始交易。
Regular Way Trading on Nasdaq Global Select Market to Begin Tomorrow, June 25
纳斯达克全球精选市场以常规方式交易将于明天6月25日开始。
GRAIL is Building and Scaling a Groundbreaking New Cancer Screening Technology
GRAIL正在建立和扩大一种开创性的新癌症筛查技术。
GRAIL, Inc. (NASDAQ:GRAL, formerly GRAIL, LLC))))), a healthcare company whose mission is to detect cancer early when it can be cured, today announced its spin-off from Illumina (NASDAQ:ILMN) is complete, and GRAIL will be listed and commence regular-way trading on the Nasdaq under the symbol "GRAL" as of tomorrow, June 25, 2024.
医疗保健公司GRAIL（纳斯达克股票代码：GRAL，原名GRAIL，LLC），其使命是在癌症能够治愈时早期检测癌症，今天宣布其与Illumina（纳斯达克股票代码：illumina）分拆完成，并将于明天6月25日在纳斯达克上市，标的为“GRAL”。